NCMP-18. NEUROTOXICITY AS A POTENTIAL SURROGATE MARKER FOR THERAPEUTIC RESPONSE WITH COMMERCIAL ANTI-CD19 CAR T-CELL THERAPY

Neurotoxicity is a common occurrence and a major form of morbidity in adult patients with relapsed or refractory (R/R) diffuse large B cell lymphoma (DLBCL) patients treated with anti-CD19 directed chimeric antigen receptor (CAR) T-cell therapy. Variables related to the incidence and severity of neu...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Neuro Oncol
Κύριοι συγγραφείς: Yuen, Carlen, Riedell, Peter, Artz, Andrew, Kosuri, Satyajit, Kelly, Thomas, Wu, Shasha, Reder, Anthony, Rezania, Kourosh, Soliven, Betty, Xie, Tao, Mastrianni, James, Park, Deric, Klejch, Wesley, Ali, Saad, Bishop, Michael
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2020
Θέματα:
Neurological Complications of Cancer
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651666/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.529
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια